Jun 20, 2023 | Drug & Alcohol Testing News
On May 29, MPs of the House of Commons defeated the motion presented by Conservative Leader Pierre Poilievre to end safe drug policies with a vote of 209 to 113. Poilievre introduced the motion to the House of Commons earlier in May, urging the Liberal government to...
Jun 16, 2023 | Drug & Alcohol Testing News
Earlier in May, the Ontario Ministry of Health gave its approval to Cochrane District EMS to administer the medication buprenorphine-naloxone, also known by its brand name Suboxone.Suboxone is classified as a narcotic and Cochrane District is the first paramedic...
Jun 13, 2023 | Drug & Alcohol Testing News
DATAC is proud to announce our second webinar of 2023, All About Oral Fluid! The landscape of drug and alcohol testing within North America is always changing and evolving and we are here with knowledgeable speakers to help you navigate those changes. The big news...
Jun 9, 2023 | Drug & Alcohol Testing News
Earlier in May, a team of researchers at St. Francis Xavier University in Nova Scotia received a research grant from the federal government to test the effectiveness of alcohol warning labels. The research team is led by Dr. Kara Thompson, the director of the...
Jun 6, 2023 | Drug & Alcohol Testing News
According to the results of the annual analysis published by Quest Diagnostics, the percentage of U.S. employees who tested positive for cannabis in 2022 reached record levels since the beginning of data collection in 1988. Specifically, over 6 million urine tests...
Jun 2, 2023 | Drug & Alcohol Testing News
Xylazine, commonly known as “tranq” or “horse tranquilizer,” has become a cause for concern in the illicit drug market. Originally used as a veterinary sedative for large animals, this drug has found its way onto the streets, especially in...
